Trials / Active Not Recruiting
Active Not RecruitingNCT03539575
CB1R in Synthetic Psychoactive Cannabinoids
CB1R Availability in Synthetic Psychoactive Cannabinoid Users
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research study is to determine whether the CB1R availability is lower in synthetic psychoactive cannabinoid subjects using the most widely available synthetic psychoactive cannabinoids at the time the study is initiated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | [11-C]OMAR | The radiotracer, \[11-C\]OMAR will be administered at no more than 10 micrograms at the beginning of each PET scan. |
Timeline
- Start date
- 2018-05-01
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2018-05-29
- Last updated
- 2025-04-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03539575. Inclusion in this directory is not an endorsement.